Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | clear.md Named As Finalist for "Startup of the Year" at Doctors 2.0 ConferenceMinneapolis-based startup is the only American company to be named as a finalist at the conference, which is focused on healthcare innovation and patient engagement.
By: clear.md “A global perspective has defined our strategy since day-one. We are honored to be recognized by Doctors 2.0 in Europe as a US-company with an international identity, and we look forward to representing the Twin Cities digital health community at the conference in Paris this June,” said John Brownlee, CEO and co-founder of clear.md. Engaging Patients Through “vidscriptionsTM” The clear.md platform allows patients to access their healthcare provider’s expertise anytime/anywhere through vidscriptionsTM; Researching Impact of Digital Health Through an ongoing series of research initiatives clear.md is building a global data set which will provide insight into the impact of digital patient engagement across a diverse group of patients and care settings. “Too often the promise of a digital health intervention is not realized due to a lack of efficacy data”, says Susan Doherty, clear.md COO. “As we increase the number of collaborative partners, one of our primary objectives is to assess the impact of vidscriptionsTM on outcomes that are important to both providers and patients.” Clear.md was founded in 2012 by John Brownlee and Brian Kuyath and is privately held. The company operates from offices in downtown Minneapolis, MN, USA. ### clear.md and vidscriptionsTM are either registered trademarks or trademarks of clear.md in the United States and/or other countries. The names of actual companies and products mentioned herein may be the trademarks of their respective owners. [MEDIA] To schedule an interview: Susan Doherty, COO 612.790.1335 sdoherty@clear.md For more information: www.clear.md End
Account Email Address Account Phone Number Disclaimer Report Abuse
|